These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 35806183)
21. Prion disease detection, PMCA kinetics, and IgG in urine from sheep naturally/experimentally infected with scrapie and deer with preclinical/clinical chronic wasting disease. Rubenstein R; Chang B; Gray P; Piltch M; Bulgin MS; Sorensen-Melson S; Miller MW J Virol; 2011 Sep; 85(17):9031-8. PubMed ID: 21715495 [TBL] [Abstract][Full Text] [Related]
22. Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer's disease and frontotemporal dementia. Das S; Goossens J; Jacobs D; Dewit N; Pijnenburg YAL; In 't Veld SGJG; Teunissen CE; Vanmechelen E Alzheimers Res Ther; 2023 Mar; 15(1):62. PubMed ID: 36964594 [TBL] [Abstract][Full Text] [Related]
23. Magnetic microparticle-based multimer detection system for the detection of prion oligomers in sheep. Lim K; Kim SY; Lee B; Segarra C; Kang S; Ju Y; Schmerr MJ; Coste J; Kim SY; Yokoyama T; An SS Int J Nanomedicine; 2015; 10(Spec Iss):241-50. PubMed ID: 26425091 [TBL] [Abstract][Full Text] [Related]
24. Review: Fluid biomarkers in the human prion diseases. Thompson AGB; Mead SH Mol Cell Neurosci; 2019 Jun; 97():81-92. PubMed ID: 30529227 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases. Thompson AGB; Anastasiadis P; Druyeh R; Whitworth I; Nayak A; Nihat A; Mok TH; Rudge P; Wadsworth JDF; Rohrer J; Schott JM; Heslegrave A; Zetterberg H; Collinge J; Jackson GS; Mead S Mol Psychiatry; 2021 Oct; 26(10):5955-5966. PubMed ID: 33674752 [TBL] [Abstract][Full Text] [Related]
26. Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment. Kern S; Syrjanen JA; Blennow K; Zetterberg H; Skoog I; Waern M; Hagen CE; van Harten AC; Knopman DS; Jack CR; Petersen RC; Mielke MM JAMA Neurol; 2019 Feb; 76(2):187-193. PubMed ID: 30419087 [TBL] [Abstract][Full Text] [Related]
27. Distinctive Toll-like Receptors Gene Expression and Glial Response in Different Brain Regions of Natural Scrapie. García-Martínez M; Cortez LM; Otero A; Betancor M; Serrano-Pérez B; Bolea R; Badiola JJ; Garza MC Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408945 [TBL] [Abstract][Full Text] [Related]
28. Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures. Falgàs N; Ruiz-Peris M; Pérez-Millan A; Sala-Llonch R; Antonell A; Balasa M; Borrego-Écija S; Ramos-Campoy O; Augé JM; Castellví M; Tort-Merino A; Olives J; Fernández-Villullas G; Blennow K; Zetterberg H; Bargalló N; Lladó A; Sánchez-Valle R Hum Brain Mapp; 2020 Jun; 41(8):2004-2013. PubMed ID: 31944489 [TBL] [Abstract][Full Text] [Related]
30. BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers. López-Pérez Ó; Bernal-Martín M; Hernaiz A; Llorens F; Betancor M; Otero A; Toivonen JM; Zaragoza P; Zerr I; Badiola JJ; Bolea R; Martín-Burriel I Biomolecules; 2020 May; 10(5):. PubMed ID: 32370154 [TBL] [Abstract][Full Text] [Related]
31. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus. Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890 [TBL] [Abstract][Full Text] [Related]
32. Neurofilament light chain in central nervous system infections: a prospective study of diagnostic accuracy. van Zeggeren IE; Ter Horst L; Heijst H; Teunissen CE; van de Beek D; Brouwer MC Sci Rep; 2022 Aug; 12(1):14140. PubMed ID: 35986031 [TBL] [Abstract][Full Text] [Related]
33. Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease. Mok TH; Nihat A; Majbour N; Sequeira D; Holm-Mercer L; Coysh T; Darwent L; Batchelor M; Groveman BR; Orr CD; Hughson AG; Heslegrave A; Laban R; Veleva E; Paterson RW; Keshavan A; Schott JM; Swift IJ; Heller C; Rohrer JD; Gerhard A; Butler C; Rowe JB; Masellis M; Chapman M; Lunn MP; Bieschke J; Jackson GS; Zetterberg H; Caughey B; Rudge P; Collinge J; Mead S Brain; 2023 Jun; 146(6):2570-2583. PubMed ID: 36975162 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study. Gagliardi D; Faravelli I; Meneri M; Saccomanno D; Govoni A; Magri F; Ricci G; Siciliano G; Pietro Comi G; Corti S J Cell Mol Med; 2021 Apr; 25(8):3765-3771. PubMed ID: 33609080 [TBL] [Abstract][Full Text] [Related]
35. Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration? Bloniecki V; Zetterberg H; Aarsland D; Vannini P; Kvartsberg H; Winblad B; Blennow K; Freund-Levi Y Alzheimers Res Ther; 2020 Nov; 12(1):153. PubMed ID: 33203439 [TBL] [Abstract][Full Text] [Related]